Boston Instruments will establish a growing presence in the $30+ billion worldwide analytical and life science instrument market – a market still dominated by U.S. companies, which comprise 57% of the global market.
Several key trends in the analytical and life science markets are providing opportunities for Boston Instruments:
• The move to more and newer instruments for life sciences applications
• A continuing increase in the need for automation
• A growing demand for process instrumentation
These trends reflect an intensified focus on quality and higher throughput in the pharmaceutical, food and beverage, and life science industries, leading to a corresponding growth in demand for new instrumentation, especially for process monitoring.
The 15 to 20 largest instrument companies make up only approximately 50% of the worldwide analytical and life science instrument market. The remaining 50% is highly fragmented with hundreds of companies. Many early stage and small companies have exceptional technology and products and are well-positioned to take advantage of the growth opportunities available. Boston Instruments targets these companies and through investment or acquisition, helps them realize their full potential and achieve increased market share and overall growth. |